These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2935497)

  • 21. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.
    Omvik P; Lund-Johansen P
    J Hypertens; 1983 Dec; 1(4):405-12. PubMed ID: 6681181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketanserin in the treatment of mild hypertension in elderly patients: preliminary results of a controlled double-blind trial.
    Dona G; Ribeiro A; Tammaro AE
    J Hypertens Suppl; 1986 Apr; 4(1):S89-90. PubMed ID: 2939220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.
    Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K
    J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.
    Hedner T; Persson B; Berglund G
    Br J Clin Pharmacol; 1983 Aug; 16(2):121-5. PubMed ID: 6615685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.
    Ferrara LA; Fasano ML; Soro S; Rubba P; Iannuzzi A
    J Clin Pharmacol; 1985 Apr; 25(3):187-92. PubMed ID: 3158674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
    Strano A; Novo S; Raineri A; Alaimo G; Abrignani MG; Cutietta A
    J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension.
    Malatino LS; Stancanelli B; Greco G; Polizzi G; Assogna G; Zanna C; Tamburino G
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():123-6. PubMed ID: 2285642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of arterial hypertension with ketanserin in mono- and combination therapy.
    Pettersson A; Persson B; Berglund G; Hedner T
    Clin Pharmacol Ther; 1985 Aug; 38(2):188-94. PubMed ID: 2861930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Moerman E; de Schaepdryver A; Amery A
    Br Heart J; 1984 Feb; 51(2):149-56. PubMed ID: 6362688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of chronic ketanserin therapy on blood pressure and certain humoral and metabolic factors in patients with mild to moderate primary essential hypertension].
    Knypl K; Wocial B; Berent H; Kuçzyńska K; Wasowska T; Brym E; Czerniewska E; Wacławek-Maczkowska J; Januszewicz W
    Pol Arch Med Wewn; 1993 Aug; 90(2):95-104. PubMed ID: 8247951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketanserin in essential hypertension: effects during rest and exercise.
    Persson B; Hedner T; Berglund G
    Eur J Clin Pharmacol; 1983; 25(3):307-12. PubMed ID: 6628517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.